NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $387,475 | -7.2% | 31,506 | +21.3% | 0.00% | 0.0% |
| Q2 2023 | $417,498 | -49.5% | 25,977 | -45.3% | 0.00% | -50.0% |
| Q1 2023 | $826,400 | +336.5% | 47,482 | +130.1% | 0.00% | – |
| Q4 2022 | $189,310 | -4.9% | 20,636 | -11.2% | 0.00% | – |
| Q3 2022 | $199,000 | -1.0% | 23,228 | -6.4% | 0.00% | – |
| Q2 2022 | $201,000 | -81.1% | 24,810 | +24.9% | 0.00% | -100.0% |
| Q1 2022 | $1,066,000 | +37.4% | 19,869 | -12.7% | 0.00% | +100.0% |
| Q4 2021 | $776,000 | -35.8% | 22,750 | -9.2% | 0.00% | -66.7% |
| Q3 2021 | $1,208,000 | -6.6% | 25,048 | -12.6% | 0.00% | 0.0% |
| Q2 2021 | $1,294,000 | +28.0% | 28,669 | +36.7% | 0.00% | +50.0% |
| Q1 2021 | $1,011,000 | -66.5% | 20,975 | -62.6% | 0.00% | -75.0% |
| Q4 2020 | $3,016,000 | +24.1% | 56,025 | -24.4% | 0.01% | +14.3% |
| Q3 2020 | $2,430,000 | -2.8% | 74,070 | -8.2% | 0.01% | -12.5% |
| Q2 2020 | $2,501,000 | -4.2% | 80,668 | -17.1% | 0.01% | -27.3% |
| Q1 2020 | $2,611,000 | – | 97,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |